|
|
|
Insider
Information: |
Scangos George A |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
934,251 |
|
Indirect Shares
|
3,765,803 |
|
|
Direct
Value |
$30,246,957 |
|
|
Indirect Value
|
$5,264,656 |
|
|
Total
Shares |
4,700,054 |
|
|
Total
Value |
$35,511,613 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
Agilent Technologies Inc |
A |
Director |
2024-05-29 |
18,578 |
2024-05-29 |
17,893 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
378 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 16
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EXEL |
Exelixis Inc |
Director |
|
2020-01-22 |
4 |
AS |
$19.75 |
$493,750 |
D/D |
(25,000) |
1,038,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-02-11 |
4 |
AS |
$20.14 |
$80,560 |
D/D |
(4,000) |
1,034,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-02-12 |
4 |
AS |
$20.02 |
$420,420 |
D/D |
(21,000) |
1,013,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-02-18 |
4 |
AS |
$20.73 |
$1,036,500 |
D/D |
(50,000) |
963,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-03-31 |
4 |
AS |
$18.06 |
$27,090 |
D/D |
(1,500) |
961,531 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-07 |
4 |
AS |
$18.25 |
$299,939 |
D/D |
(16,435) |
945,096 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-08 |
4 |
AS |
$18.35 |
$129,643 |
D/D |
(7,065) |
938,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-15 |
4 |
AS |
$18.31 |
$457,750 |
D/D |
(25,000) |
913,031 |
0 |
% |
|
A |
Agilent Technologies Inc |
Director |
|
2020-04-17 |
4 |
A |
$73.01 |
$299,921 |
D/D |
4,108 |
27,887 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-20 |
4 |
AS |
$23.39 |
$1,194,637 |
D/D |
(50,000) |
863,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-21 |
4 |
AS |
$25.04 |
$145,232 |
D/D |
(5,800) |
857,231 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-22 |
4 |
AS |
$25.05 |
$105,210 |
D/D |
(4,200) |
853,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-23 |
4 |
AS |
$25.68 |
$2,598,635 |
D/D |
(100,000) |
753,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-04-24 |
4 |
AS |
$26.24 |
$393,600 |
D/D |
(15,000) |
738,031 |
0 |
% |
|
EXEL |
Exelixis Inc |
Director |
|
2020-05-15 |
4 |
OE |
$4.58 |
$263,613 |
D/D |
51,686 |
789,717 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2020-05-18 |
4 |
AS |
$25.96 |
$1,947,000 |
D/D |
(75,000) |
714,717 |
0 |
% |
|
A |
Agilent Technologies Inc |
Director |
|
2020-08-03 |
4 |
A |
$93.91 |
$16,622 |
D/D |
177 |
28,112 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2021-03-18 |
4 |
A |
$121.59 |
$344,838 |
D/D |
2,836 |
16,544 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2022-03-17 |
4 |
A |
$136.82 |
$244,224 |
D/D |
1,785 |
18,420 |
0 |
- |
|
A |
Agilent Technologies Inc |
Director |
|
2023-03-16 |
4 |
A |
$136.82 |
$226,848 |
D/D |
1,658 |
20,185 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-09-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,377,590) |
0 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-09-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,750,000 |
1,750,000 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750,000 |
1,918,489 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-10-17 |
4 |
A |
$0.00 |
$0 |
I/I |
3,500,000 |
1,750,000 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-10-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,750,000) |
0 |
0 |
- |
|
378 Records found
|
|
Page 6 of 16 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|